Sihuan Pharmaceutical Holdings Group Ltd.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SHPHF research report →
About the company
Sihuan Pharmaceutical Holdings Group Ltd. engages in the research and development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Medical Aesthetic Products, Innovative Medicine and Other Medicine, and Generic Medicine.
- CEO
- Wei Cheng Guo
- IPO
- 2012
- Employees
- 2,843
- HQ
- Wan Chai, CN
Price Chart
- Market Cap
- $1.17B
- P/E
- 38.71
- P/S
- 2.66
- P/B
- 1.19
- EV/EBITDA
- 6.85
- Div Yield
- 1.22%
- Gross Margin
- 68.83%
- Op Margin
- 23.19%
- Net Margin
- 6.86%
- ROE
- 3.51%
- ROIC
- 3.28%
- Revenue
- $2.55B · 34.16%
- Net Income
- $175.06M · 180.80%
- EPS
- $0.02 · 180.77%
- Op Income
- $382.35M
- FCF YoY
- -479.16%
- 52W High
- $0.21
- 52W Low
- $0.05
- 50D MA
- $0.18
- 200D MA
- $0.12
- Beta
- 0.87
- Avg Volume
- 1.66K
Get TickerSpark's AI analysis on SHPHF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our SHPHF coverage
Recent articles, reports, and earnings notes.
No research on SHPHF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate SHPHF report →Similar companies
Peers in the same neighborhood.